Sanguinarine (SAG) could reduce the protein stability of GPX4 via E3 ligase STUB1-induced ubiquitination and degradation of GPX4, then increase ROS, MDA, and Fe2+ levels, and finally cause the ferroptosis of NSCLCs and suppress tumor growth and metastasis in vivo [41]. Here, GPX4 is linked to neoplasm.